American scientists from the University of Pittsburgh have made a breakthrough in the late treatment of anthrax, developing a method that can reverse the final damage to cells. The study was published in the Journal of NATMICROBIO (NATMICROBIO).
The team found that a cocktail of growth factors could trigger important cell paths that were damaged by toxins of anthrax. This approach has shown its effectiveness in mice experiments, increasing the survival of experimental animals even after the disease has reached the “non -recovery point”. The use of the potential of Bacillus Anthracis as a particularly alarming biological weapon.
“The initial symptoms of coal disease are easily confused with the flu, which often leads to late diagnosis. When the disease is late, modern treatments become almost useless,” the authors of Discovery note.
The researchers have found that a deadly toxin of an inactivated Mek's main enzyme, violating the most important cell processes. However, the combination of three approved growth factors for clinical use of growth factors that can restore the work of ERK and P38 is damaged, which is a surprise for scientists themselves. Now the group is working to adjust the method of treating people, saying that different types of cells may require different combinations of growth factors.